CASI Pharmaceuticals - Bathi saben saham sajrone rolas wulan pungkasan CASI

CASI Pharmaceuticals maintains a high authority in oncohematology and strong physician trust, ensuring stable growth. The rolling net income per share chart visualizes this success, where -3.02 serves as the parameter's baseline value. Business efficiency is bolstered by the licensing of Western drugs for China, which minimizes R&D risks, as well as strict adherence to ESG standards regarding hazardous waste disposal and eco-packaging.

CASI Bathi resik saben siji saham sajrone rolas wulan pungkasan CASI Pharmaceuticals, Inc (04.07.2022 - 14.03.2026)

CASI (CASI Pharmaceuticals Inc.): rincian analitis lan laporan miturut indikator

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega CASI Pharmaceuticals, Inc|CASI - Bagan rega target

- rincian nilai pasar emiten:

Nilai pasar CASI Pharmaceuticals, Inc.|CASI - Total Nilai Perusahaan

- data nilai buku modal saham:

Aset Bersih saben Siji Saham CASI Pharmaceuticals|CASI - Ekuitas Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku casipharmaceuticals.com|CASI - Total Aset Bisnis

- rincian utang lan likuiditas:

Total Utang marang Modal CASI Pharmaceuticals|CASI - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal CASI Pharmaceuticals, Inc|CASI - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku CASI Pharmaceuticals, Inc.|CASI - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan CASI Pharmaceuticals|Indikator likuiditas cepet casipharmaceuticals.com

- data bathi lan kelipatan valuasi:

CASI - Bathi pungkasan|Bathi sing dikarepake CASI Pharmaceuticals|CASI - Kapitalisasi marang bathi resik|Pangali Forward P/E CASI Pharmaceuticals, Inc|CASI - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA CASI Pharmaceuticals, Inc.|CASI - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan CASI Pharmaceuticals|CASI - Bathi saben saham sajroning taun lumaku|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan casipharmaceuticals.com|CASI - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep CASI Pharmaceuticals

Analisis kabeh metrik perusahaan:CASI - casipharmaceuticals.com

Produk sing diprodhuksi CASI Pharmaceuticals Inc.

Investors seek a fundamental anchor in profit generation efficiency. For CASI Pharmaceuticals (CASI), high expansion costs in China temporarily exceed revenue, creating a liquidity deficit. This rolling net income per share snapshot measures the final income allocated to a single share per year. Positive momentum in this metric confirms business resilience, while a decline in the indicator signals risks of overpaying for the asset.

Pesaing CASI Pharmaceuticals